The American Society of Hematology Self-Assessment Program (ASH-SAP), Sixth Edition, is now available online at http://www.hematology.org/ashsap. This most recent edition of the ASH-SAP is our most comprehensive edition to date, encompassing both adult and pediatric hematology, including both benign and malignant disorders. With 23 significantly updated chapters, newly rendered illustrations, and nearly 300 questions, the ASH-SAP is designed for self-directed learning and review with case studies, key points, graphics, animation, audio, and glossaries. Take advantage of the new online-only features, including animation and audio, as added enhancements to the Sixth Edition.
A major goal of ASH-SAP is to provide challenging and informative multiple-choice questions through the Question and Answer Book (included with the textbook) for hematologists studying for professional certification or recertification exams. Successful completion of this activity, which includes participation in the evaluation component, enables the participant to earn up to 70 Continuing Medical Education (CME) and Maintenance of Certification (MOC) points in the American Board of Internal Medicine’s MOC program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.
To claim up to 70 CME/MOC credits based on the ASH-SAP Sixth Edition, visit the ASH Academy Testing Center at http://www.ashacademy.org.
About the Editors
DAVID P. STEENSMA, MD (Senior Executive Editor)
Dr. Steensma is a Senior Physician in the Division of Hematologic Malignancies at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School. Dr. Steensma’s clinical and research interests include molecular genetics of myeloid neoplasia and development of novel therapies for myelodysplastic syndromes, sideroblastic anemias, and bone marrow failure.
ADAM CUKER, MD, MS (Junior Executive Editor)
Dr. Cuker is Assistant Professor of Medicine and Pathology & Laboratory Medicine at the University of Pennsylvania. He received his MD from Yale University and completed internship and residency in internal medicine at Brigham and Women’s Hospital and Harvard Medical School. He continued his training at the University of Pennsylvania, where he was a fellow in hematology/oncology. He holds a master’s degree in translational research from the University of Pennsylvania. He is Director of the Penn Comprehensive Hemophilia & Thrombosis Program, Clinical Director of the Penn Blood Disorders Center, and Associate Director for Clinical Research of the Penn-CHOP Blood Center.
CHRISTINE L. KEMPTON, MD, MSc (Associate Editor—Medical Education)
Dr. Kempton is an Associate Professor at Emory University School of Medicine and the Director of the Comprehensive Bleeding Disorders Center at Emory University and Children’s Healthcare of Atlanta. Dr. Kempton’s clinical focus is on bleeding and thrombotic disorders, and her research focuses on complications of bleeding disorders in adults, such as inhibitor development in patients with mild and moderate hemophilia A and low bone density.
RZEGORZ S. NOWAKOWSKI, MD (Associate Editor—Question Writing)
Dr. Nowakowski is a Consultant in the Division of Hematology at Mayo Clinic—Rochester and Assistant Professor of Medicine at Mayo Clinic. Dr. Nowakowski’s clinical and research interests include the biology of lymphoid malignancies and development of novel, molecularly driven therapies for lymphoma.